• Published On : Sep-2016 |
  • Pages : 209 Pages |
  • Format :

Table of Contents

1. Executive Summary

2. Assumptions and Acronyms

3. Research Methodology

4. Diabetic Gastroparesis Treatment Market Overview
   4.1.Introduction
       4.1.1.Diabetic Gastroparesis Treatment Market Definition
       4.1.2.Diabetic Gastroparesis Treatment Market Taxonomy
       4.1.3.Diabetic Gastroparesis Treatment Market Product Type Overview
       4.1.4. Overview
   4.2.Diabetic Gastroparesis Treatment Market Dynamics
       4.2.1.Drivers
       4.2.2.Restraints
       4.2.3.Opportunity
       4.2.4.Value Chain
   4.3.Pipeline Assessment
   4.4.Regulations &Reimbursement Scenario
   4.5.Disease Epidemiology, By Region

5. Global Diabetic Gastroparesis Treatment Market Forecast
   5.1.Market Value (US$ Mn) Forecast
       5.1.1.Y-o-Y Growth Projections
       5.1.2.Absolute $ Opportunity
   5.2.Diabetic Gastroparesis Treatment Market Trends
   5.3.Regional Average Pricing Analysis (2015)
   5.4.Global Diabetic Gastroparesis Treatment Market Snapshot (2015)
       5.4.1.Market Share, By Region
       5.4.2.Market Share, By Product Type 
       5.4.3.Market Share, By Distribution Channel 
       5.4.4.Market Share, By Disease Indication 

6. Global Diabetic Gastroparesis Treatment Market Analysis, By Product Type 
   6.1.Introduction
       6.1.1.Y-o-Y Growth Comparison, By Product Type 
       6.1.2.Market Share & Basis Point (BPS) Analysis, By Product Type 
   6.2.Market Forecast, By Product Type 
       6.2.1.Drugs
             6.2.1.1.Absolute $ Opportunity
             6.2.1.2.Market Value (US$ Mn) Forecast
             6.2.1.3.Gastroprokinetic Agents
             6.2.1.4.Antiemetic Agents
             6.2.1.5.Botulinum Toxin
       6.2.2.Surgical Treatment Products
             6.2.2.1.Absolute $ Opportunity
             6.2.2.2.Market Value (US$ Mn) Forecast
             6.2.2.3.Gastric Electrical Stimulation (GES) Devices
             6.2.2.4.Percutaneous Endoscopic Gastrostomy (PEG) Kit
             6.2.2.5.Parenteral Nutrition
   6.3.Market Attractiveness Analysis, By Product Type 
   6.4.Prominent Trends

7. Global Diabetic Gastroparesis Treatment Market Analysis, By Disease Indication 
   7.1.Introduction
       7.1.1.Y-o-Y Growth Comparison, By Disease Indication 
       7.1.2.Market Share & Basis Point (BPS) Analysis, By Disease Indication 
   7.2.Market Forecast, By Disease Indication 
       7.2.1.Compensated Gastroparesis
             7.2.1.1.Absolute $ Opportunity
             7.2.1.2.Market Value (US$ Mn) Forecast
       7.2.2.Gastric Failure
             7.2.2.1.Absolute $ Opportunity
             7.2.2.2.Market Value (US$ Mn) Forecast
   7.3.Market Attractiveness Analysis, By Disease Indication 
   7.4.Prominent Trends

8. Global Diabetic Gastroparesis Treatment Market Analysis, By Distribution Channel 
   8.1.Introduction
       8.1.1.Y-o-Y Growth Comparison, By Distribution Channel 
       8.1.2.Market Share & Basis Point (BPS) Analysis, By Distribution Channel 
   8.2.Market Forecast, By Distribution Channel 
       8.2.1.Hospital Pharmacies
             8.2.1.1.Absolute $ Opportunity
             8.2.1.2.Market Value (US$ Mn) Forecast
       8.2.2.Private Clinics
             8.2.2.1.Absolute $ Opportunity
             8.2.2.2.Market Value (US$ Mn) Forecast
       8.2.3.Drug Stores
             8.2.3.1.Absolute $ Opportunity
             8.2.3.2.Market Value (US$ Mn) Forecast
       8.2.4.Retail Pharmacies
             8.2.4.1.Absolute $ Opportunity
             8.2.4.2.Market Value (US$ Mn) Forecast
       8.2.5.E-commerce
             8.2.5.1.Absolute $ Opportunity
             8.2.5.2.Market Value (US$ Mn) Forecast

9. Global Diabetic Gastroparesis Treatment Market Analysis, By Region
   9.1.Introduction
       9.1.1.Y-o-Y Growth Projections, By Region
       9.1.2.Market Share & Basis Point (BPS) Analysis, By Region
   9.2.Market Forecast, By Region
       9.2.1.North America Market Value (US$ Mn) Forecast
       9.2.2.Latin AmericaMarket Value (US$ Mn) Forecast
       9.2.3.Europe Market Value (US$ Mn) Forecast
       9.2.4.APAC Market Value (US$ Mn) Forecast
       9.2.5.MEA Market Value (US$ Mn) Forecast
   9.3.Regional Attractiveness Analysis

10. North America Diabetic Gastroparesis Treatment Market Analysis
   10.1. Introduction
       10.1.1. Y-o-Y Growth Projections, By Country
       10.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   10.2. Key Regulations
   10.3. Key Trends
   10.4. North America Market Forecast
       10.4.1. Market Value (US$ Mn) Forecast, By Country
             10.4.1.1.U.S. Absolute $ Opportunity
             10.4.1.2.Canada Absolute $ Opportunity
       10.4.2. Market Value (US$ Mn) Forecast, By Product Type 
             10.4.2.1.Drugs
                      10.4.2.1.1. Gastroprokinetic Agents
                      10.4.2.1.2. Antiemetic Agents
                      10.4.2.1.3. Botulinum Toxin
             10.4.2.2.Surgical Treatment Products
                      10.4.2.2.1. Gastric Electrical Stimulation (GES) Devices
                      10.4.2.2.2. Percutaneous Endoscopic Gastrostomy (PEG) Kit
                      10.4.2.2.3. Parenteral Nutrition
       10.4.3. Market Value (US$ Mn) Forecast, By Disease Indication 
             10.4.3.1.Compensated Gastroparesis
             10.4.3.2.Gastric Failure
       10.4.4. Market Value (US$ Mn) Forecast, By Distribution Channel
             10.4.4.1.Hospital Pharmacies
             10.4.4.2.Private Clinics
             10.4.4.3.Drug Stores
             10.4.4.4. Retail Pharmacies
             10.4.4.5. E-commerce
   10.5. Market Attractiveness Analysis
       10.5.1. By Country
       10.5.2. By Product Type 
       10.5.3. By Distribution Channel 
       10.5.4. By Disease Indication 

11. Latin AmericaDiabetic Gastroparesis Treatment Market Analysis
   11.1. Introduction
       11.1.1. Y-o-Y Growth Projections, By Country
       11.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   11.2. Key Regulations
   11.3. Key Trends
   11.4. Latin America Market Forecast
       11.4.1. Market Value (US$ Mn) Forecast, By Country
             11.4.1.1.Brazil Absolute $ Opportunity
             11.4.1.2.Mexico Absolute $ Opportunity
             11.4.1.3.Rest of Latin America Absolute $ Opportunity
       11.4.2. Market Value (US$ Mn) Forecast, By Product Type 
             11.4.2.1.Drugs
                      11.4.2.1.1. Gastroprokinetic Agents
                      11.4.2.1.2. Antiemetic Agents
                      11.4.2.1.3. Botulinum Toxin
             11.4.2.2.Surgical Treatment Products
                      11.4.2.2.1. Gastric Electrical Stimulation (GES) Devices
                      11.4.2.2.2. Percutaneous Endoscopic Gastrostomy (PEG) Kit
                      11.4.2.2.3. Parenteral Nutrition
       11.4.3. Market Value (US$ Mn) Forecast, By Disease Indication 
             11.4.3.1.Compensated Gastroparesis
             11.4.3.2.Gastric Failure
       11.4.4. Market Value (US$ Mn) Forecast, By Distribution Channel
             11.4.4.1.Hospital Pharmacies
             11.4.4.2.Private Clinics
             11.4.4.3.Drug Stores
             11.4.4.4. Retail Pharmacies
             11.4.4.5.E-commerce
   11.5. Market Attractiveness Analysis
       11.5.1. By Country
       11.5.2. By Product Type 
       11.5.3. By Distribution Channel 
       11.5.4. By Disease Indication 

12. Europe Diabetic Gastroparesis Treatment Market Analysis
   12.1. Introduction
       12.1.1. Y-o-Y Growth Projections, By Country
       12.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   12.2. Key Regulations
   12.3. Key Trends
   12.4. Europe Market Forecast
       12.4.1. Market Value (US$ Mn) Forecast, By Country
             12.4.1.1.EU5 Absolute $ Opportunity
             12.4.1.2.Russia Absolute $ Opportunity
             12.4.1.3.Rest of Europe Absolute $ Opportunity
       12.4.2. Market Value (US$ Mn) Forecast, By Product Type 
             12.4.2.1.Drugs
                      12.4.2.1.1. Gastroprokinetic Agents
                      12.4.2.1.2. Antiemetic Agents
                      12.4.2.1.3. Botulinum Toxin
             12.4.2.2.Surgical Treatment Products
                      12.4.2.2.1. Gastric Electrical Stimulation (GES) Devices
                      12.4.2.2.2. Percutaneous Endoscopic Gastrostomy (PEG) Kit
                      12.4.2.2.3. Parenteral Nutrition
       12.4.3. Market Value (US$ Mn) Forecast, By Disease Indication 
             12.4.3.1.Compensated Gastroparesis
             12.4.3.2.Gastric Failure
       12.4.4. Market Value (US$ Mn) Forecast, By Distribution Channel
             12.4.4.1.Hospital Pharmacies
             12.4.4.2.Private Clinics
             12.4.4.3.Drug Stores
             12.4.4.4. Retail Pharmacies
             12.4.4.5. E-commerce
   12.5. Market Attractiveness Analysis
       12.5.1. By Country
       12.5.2. By Product Type 
       12.5.3. By Distribution Channel 
       12.5.4. By Disease Indication 

13. APAC Diabetic Gastroparesis Treatment Market Analysis
   13.1. Introduction
       13.1.1. Y-o-Y Growth Projections, By Country
       13.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   13.2. Key Regulations
   13.3. Key Trends
   13.4. APAC Market Forecast
       13.4.1. Market Value (US$ Mn) Forecast, By Country
             13.4.1.1.China Absolute $ Opportunity
             13.4.1.2.Japan Absolute $ Opportunity
             13.4.1.3.Australia & New Zealand Absolute $ Opportunity
             13.4.1.4.ASEANAbsolute $ Opportunity
             13.4.1.5.Rest of APAC Absolute $ Opportunity
       13.4.2. Market Value (US$ Mn) Forecast, By Product Type 
             13.4.2.1.Drugs
                      13.4.2.1.1. Gastroprokinetic Agents
                      13.4.2.1.2. Antiemetic Agents
                      13.4.2.1.3. Botulinum Toxin
             13.4.2.2.Surgical Treatment Products
                      13.4.2.2.1. Gastric Electrical Stimulation (GES) Devices
                      13.4.2.2.2. Percutaneous Endoscopic Gastrostomy (PEG) Kit
                      13.4.2.2.3. Parenteral Nutrition
       13.4.3. Market Value (US$ Mn) Forecast, By Disease Indication 
             13.4.3.1.Compensated Gastroparesis
             13.4.3.2.Gastric Failure
       13.4.4. Market Value (US$ Mn) Forecast, By Distribution Channel
             13.4.4.1.Hospital Pharmacies
             13.4.4.2.Private Clinics
             13.4.4.3.Drug Stores
             13.4.4.4. Retail Pharmacies
             13.4.4.5. E-commerce
   13.5. Market Attractiveness Analysis
       13.5.1. By Country
       13.5.2. By Product Type 
       13.5.3. By Distribution Channel 
       13.5.4. By Disease Indication 

14. MEA Diabetic Gastroparesis Treatment Market Analysis
   14.1. Introduction
       14.1.1. Y-o-Y Growth Projections, By Country
       14.1.2. Market Share & Basis Point (BPS) Analysis, By Country
   14.2. Key Regulations
   14.3. Key Trends
   14.4. MEA Market Forecast
       14.4.1. Market Value (US$ Mn) Forecast, By Country
             14.4.1.1.GCC Countries Absolute $ Opportunity
             14.4.1.2.South Africa Absolute $ Opportunity
             14.4.1.3.Rest of MEA Absolute $ Opportunity
       14.4.2. Market Value (US$ Mn) Forecast, By Product Type 
             14.4.2.1.Drugs
                      14.4.2.1.1. Gastroprokinetic Agents
                      14.4.2.1.2. Antiemetic Agents
                      14.4.2.1.3. Botulinum Toxin
             14.4.2.2.Surgical Treatment Products
                      14.4.2.2.1. Gastric Electrical Stimulation (GES) Devices
                      14.4.2.2.2. Percutaneous Endoscopic Gastrostomy (PEG) Kit
                      14.4.2.2.3. Parenteral Nutrition
       14.4.3. Market Value (US$ Mn) Forecast, By Disease Indication 
             14.4.3.1.Compensated Gastroparesis
             14.4.3.2.Gastric Failure
       14.4.4. Market Value (US$ Mn) Forecast, By Distribution Channel
             14.4.4.1.Hospital Pharmacies
             14.4.4.2.Private Clinics
             14.4.4.3.Drug Stores
             14.4.4.4. Retail Pharmacies
             14.4.4.5. E-commerce
   14.5. Market Attractiveness Analysis
       14.5.1. By Country
       14.5.2. By Product Type 
       14.5.3. By Distribution Channel 
       14.5.4. By Disease Indication 

15.Competition Landscape
   15.1.Competition Dashboard
   15.2.Company Profiles Inclusions
       15.2.1.Revenue
       15.2.2.Products/Brand Offerings
       15.2.3.Key developments
       15.2.4.SWOT Analysis
   15.3.Company Profiles
       15.3.1.Janssen Global Services, LLC
       15.3.2.Evoke Pharma
       15.3.3.Cardinal Health, Inc.
       15.3.4.Salix Pharmaceuticals, Inc.
       15.3.5.Alfa Wassermann SPA
       15.3.6.Abbott Laboratories
       15.3.7.Medtronic Plc.
       15.3.8.C. R. Bard, Inc. 
       15.3.9.Rhythm Pharmaceuticals, Inc.
       15.3.10.Boston Scientific Corporation
       15.3.11.Kimberly-Clark Corporation


List of Tables

Table 01 : Global Diabetic Gastroparesis Treatment Market Size and Forecast By Product Type (US$ Mn) (2016–2024)
Table 02 : Global Diabetic Gastroparesis Treatment Market Size and Forecast By Disease Indication (US$ Mn) (2016–2024)
Table 03 : Global Diabetic Gastroparesis Treatment Market Size and Forecast By Distribution Channel (US$ Mn) (2016–2024)
Table 04 : Global Diabetic Gastroparesis Treatment Market Size and Forecast By Region (US$ Mn) (2016–2024)
Table 05 : North America Diabetic Gastroparesis Treatment Market Size and Forecast By Country (US$ Mn) (2016–2024)
Table 06 : North America Diabetic Gastroparesis Treatment Market Size and Forecast By Product Type (US$ Mn) (2016–2024)
Table 07 : North America Diabetic Gastroparesis Treatment Market Size and Forecast By Disease Indication (US$ Mn) (2016–2024)
Table 08 : North America Diabetic Gastroparesis Treatment Market Size and Forecast By Distribution Channel (US$ Mn) (2016–2024)
Table 09 : Latin America Diabetic Gastroparesis Treatment Market Size and Forecast By Country (US$ Mn) (2016–2024)
Table 10 : Latin America Diabetic Gastroparesis Treatment Market Size and Forecast By Product Type (US$ Mn) (2016–2024)
Table 11 : Latin America Diabetic Gastroparesis Treatment Market Size and Forecast By Disease Indication (US$ Mn) (2016–2024)
Table 12 : Latin America Diabetic Gastroparesis Treatment Market Size and Forecast By Distribution Channel (US$ Mn) (2016–2024)
Table 13 : Europe Diabetic Gastroparesis Treatment Market Size and Forecast By Country (US$ Mn) (2016–2024)
Table 14 : Europe Diabetic Gastroparesis Treatment Market Size and Forecast By Product Type (US$ Mn) (2016–2024)
Table 15 : Europe Diabetic Gastroparesis Treatment Market Size and Forecast By Disease Indication (US$ Mn) (2016–2024)
Table 16 : Europe Diabetic Gastroparesis Treatment Market Size and Forecast By Distribution Channel (US$ Mn) (2016–2024)
Table 17 : APAC Diabetic Gastroparesis Treatment Market Size and Forecast By Country (US$ Mn) (2016–2024)
Table 18 : APAC Diabetic Gastroparesis Treatment Market Size and Forecast By Product Type (US$ Mn) (2016–2024)
Table 19 : APAC Diabetic Gastroparesis Treatment Market Size and Forecast By Disease Indication (US$ Mn) (2016–2024)
Table 20 : APAC Diabetic Gastroparesis Treatment Market Size and Forecast By Distribution Channel (US$ Mn) (2016–2024)
Table 21 : MEA Diabetic Gastroparesis Treatment Market Size and Forecast By Country (US$ Mn) (2016–2024)
Table 22 : MEA Diabetic Gastroparesis Treatment Market Size and Forecast By Product Type (US$ Mn) (2016–2024)
Table 23 : MEA Diabetic Gastroparesis Treatment Market Size and Forecast By Disease Indication (US$ Mn) (2016–2024)
Table 24 : MEA Diabetic Gastroparesis Treatment Market Size and Forecast By Distribution Channel (US$ Mn) (2016–2024)


List of Figures

Figure 01: Global Diabetic Gastroparesis Treatment Market, 2015
Figure 02: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2016–2024
Figure 03: Global Diabetic Gastroparesis Treatment Market Absolute $ Opportunity, 2016–2024
Figure 04: Global Diabetic Gastroparesis Treatment Market Share and BPS Analysis (%) By Product Type, 2016 & 2024
Figure 05: Global Diabetic Gastroparesis Treatment Market Y-o-Y growth (%) By Product Type, 2016–2024
Figure 06: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024) By Drug Segment
Figure 07: Global Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity By Drug Segment, 2016–2024
Figure 08: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024) By Botulinum Toxin Sub-segment
Figure 09: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024) By Gastroprokinetic Agents Sub-segment
Figure 10: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024) By Antiemetic Agents Sub-segment
Figure 11: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024) By Surgical Treatment Products Segment
Figure 12: Global Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity By Surgical Treatment Products Segment, 2016–2024
Figure 13: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024) By Parenteral Nutrition Sub-segment
Figure 14: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024) By Gastric Electrical Stimulation (GES) Device Sub-segment
Figure 15: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024) By Percutaneous Endoscopic Gastrostomy (PEG) Kit Sub-segment
Figure 16: Global Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Product Type, 2016–2024
Figure 17: Global Diabetic Gastroparesis Treatment Market Share and BPS Analysis (%) By Disease Indication, 2016 & 2024
Figure 18: Global Diabetic Gastroparesis Treatment Market Y-o-Y growth (%) By Disease Indication, 2016–2024
Figure 19: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024) By Compensated Gastroparesis Segment
Figure 20: Global Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity By Compensated Gastroparesis Segment, 2016–2024
Figure 21: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024) By Gastric Failure Segment
Figure 22: Global Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity By Gastric Failure Segment, 2016–2024
Figure 23: Global Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Disease Indication, 2016–2024
Figure 24: Global Diabetic Gastroparesis Treatment Market Share and BPS Analysis (%) By Distribution Channel, 2016 & 2024
Figure 25: Global Diabetic Gastroparesis Treatment Market Y-o-Y growth (%) By Distribution Channel, 2016–2024
Figure 26: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024) By Hospital Pharmacies Segment
Figure 27: Global Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity By Hospital Pharmacies Segment, 2016–2024
Figure 28: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024) By Private Clinics Segment
Figure 29: Global Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity By Private Clinics Segment, 2016–2024
Figure 30: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024) By Drug Stores Segment
Figure 31: Global Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity By Drug Stores Segment, 2016–2024
Figure 32: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024) By Retail Pharmacies Segment
Figure 33: Global Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity By Retail Pharmacies Segment, 2016–2024
Figure 34: Global Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024) By E-commerce Segment
Figure 35: Global Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity By E-commerce Segment, 2016–2024
Figure 36: Global Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 37: Europe Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 38: North America Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 39: Latin America Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 40: APAC Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 41: MEA Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 42: Global Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Region, 2016–2024
Figure 43: North America Diabetic Gastroparesis Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 44: North America Diabetic Gastroparesis Treatment Market Y-o-Y growth (%) By Country, 2016–2024
Figure 45: The U.S Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 46: The U.S Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016–2024
Figure 47: Canada Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 48: Canada Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016–2024
Figure 49: North America Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Country, 2016–2024
Figure 50: North America Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Product Type, 2016–2024
Figure 51: North America Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Disease Indication, 2016–2024
Figure 52: North America Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 53: Latin America Diabetic Gastroparesis Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 54: Latin America Diabetic Gastroparesis Treatment Market Y-o-Y growth (%) By Country, 2016–2024
Figure 55: Brazil Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 56: Brazil Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016–2024
Figure 57: Mexico Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 58: Mexico Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016–2024
Figure 59: Rest of Latin America Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 60: Rest of Latin America Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016–2024
Figure 61: Latin America Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Country, 2016–2024
Figure 62: Latin America Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Product Type, 2016–2024
Figure 63: Latin America Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Disease Indication, 2016–2024
Figure 64: Latin America Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 65: Europe Diabetic Gastroparesis Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 66: Europe Diabetic Gastroparesis Treatment Market Y-o-Y growth (%) By Country, 2016–2024
Figure 67: EU5 Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 68: EU5 Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016–2024
Figure 69: Russia Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 70: Russia Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016–2024
Figure 71: Rest of Europe Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 72: Rest of Europe Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016–2024
Figure 73: Europe Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Country, 2016–2024
Figure 74: Europe Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Product Type, 2016–2024
Figure 75: Europe Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Disease Indication, 2016–2024
Figure 76: Europe Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 77: APAC Diabetic Gastroparesis Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 78: APAC Diabetic Gastroparesis Treatment Market Y-o-Y growth (%) By Country, 2016–2024
Figure 79: China Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 80: China Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016–2024
Figure 81: Japan Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 82: Japan Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016–2024
Figure 83: Australia & New Zealand Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 84: Australia & New Zealand Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016–2024
Figure 85: ASEAN Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 86: ASEAN Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016–2024
Figure 87: Rest of APAC Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 88: Rest of APAC Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016–2024
Figure 89: APAC Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Country, 2016–2024
Figure 90: APAC Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Product Type, 2016–2024
Figure 91: APAC Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Disease Indication, 2016–2024
Figure 92: APAC Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 93: MEA Diabetic Gastroparesis Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 94: MEA Diabetic Gastroparesis Treatment Market Y-o-Y growth (%) By Country, 2016–2024
Figure 95: GCC Countries Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 96: GCC Countries Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016–2024
Figure 97: South Africa Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 98: South Africa Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016–2024
Figure 99: Rest of MEA Diabetic Gastroparesis Treatment Market Value (US$ Mn) Forecast (2016–2024)
Figure 100: Rest of MEA Diabetic Gastroparesis Treatment Market Absolute US$ Opportunity, 2016–2024
Figure 101: MEA Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Country, 2016–2024
Figure 102: MEA Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Product Type, 2016–2024
Figure 103: MEA Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Disease Indication, 2016–2024
Figure 104: MEA Diabetic Gastroparesis Treatment Market Attractiveness Analysis By Distribution Channel, 2016–2024